Meeting
2018 Genitourinary Cancers Symposium
Immunotherapy for biochemically recurrent prostate cancer.
Authors
Ravi Amrit Madan
National Cancer Institute, Bethesda, MD
Ravi Amrit Madan , Fatima Karzai , Marijo Bilusic , Julius Strauss , Susan F. Slovin , Lauren Christine Harshman , Marc Robert Theoret , Philip M. Arlen , Myrna Rauckhorst , Anna Couvillon , Amy Hankin , Monique Williams , Philip W. Kantoff , William L. Dahut , Jeffrey Schlom , James L. Gulley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Clinical Trial Registration Number
NCT02649439
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 215)
DOI
10.1200/JCO.2018.36.6_suppl.215
Abstract #
215
Poster Bd #
K13
Abstract Disclosures
Similar Posters
Poster
2013 Genitourinary Cancers Symposium
Current status and outcomes of salvage radiotherapy for patients with PSA recurrence after prostatectomy: A JROSG surveillance study.
First Author: Takashi Mizowaki
Poster
2020 Genitourinary Cancers Symposium
Redefining the role of adjuvant versus salvage radiation therapy for prostate cancer after radical prostatectomy for T3 disease and/or positive margins.
First Author: Barry W. Goy
Poster
2014 ASCO Annual Meeting
Cancer immunotherapy of patients with the biochemical relapse of the prostate cancer using dendritic cell-based vaccine DCVAC/PCa.
First Author: Radek Spisek
Poster
2024 ASCO Genitourinary Cancers Symposium
Enzalutamide combination treatment (tx) suspension in men with high-risk biochemically recurrent (BCR) prostate cancer: Outcomes from EMBARK.
First Author: Stephen J. Freedland